文献速递泌尿生殖MR

PI-RADSv2与ADC参数在区分Gleason 3+4与4+3前列腺癌中的预测作用

Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

回顾性纳入119例Gleason评分7分前列腺癌患者,以根治性前列腺切除标本为参考标准,比较PI-RADSv2定性评分与ADC定量参数区分Gleason模式3+4与4+3的能力。ADCratio在两组间有显著差异(p=0.001),PI-RADSv2评分无显著差异(p=0.17);回归分析选择ADCT(p=0.03)和ADCratio(p=0.0007)作为最佳预测因子,预测模型区分GP 4+3与3+4的敏感度、特异度和准确率分别为37%、82%和66%。结论认为ADC参数能以高特异度和中等准确率区分GP 3+4与4+3,而PI-RADSv2未能区分。

要点

  • ADCratio在Gleason 3+4与4+3两组间差异显著(p=0.001),PI-RADSv2评分无显著差异(p=0.17)。
  • 回归分析选择ADCT(p=0.03)和ADCratio(p=0.0007)作为区分GP 4+3与3+4的最佳预测因子。
  • 预测模型区分GP 4+3与3+4的敏感度37%、特异度82%、准确率66%。

核心结论

  • ADC参数能以高特异度和中等准确率区分Gleason模式3+4与4+3前列腺癌,而PI-RADSv2未能区分这两种模式。

研究设计与样本

  • 回顾性研究,纳入119例初治外周带和移行带Gleason评分7分前列腺癌患者,行3T多参数前列腺MRI(DWI b值0、1400,不可用时0、500)并接受根治性前列腺切除术,以切除标本病理为参考标准;由对病理数据不知情的放射科医生为每个MRI病灶赋值PI-RADSv2评分。

关键影像表现/征象

  • PI-RADSv2评分(低风险 vs 高风险)在Gleason模式3+4与4+3两组间无显著差异(p=0.17)。
  • ADCratio(肿瘤ADC/邻近正常组织ADC)在Gleason模式3+4与4+3两组间差异显著(p=0.001)。

诊断标准与关键数值

  • PI-RADSv2评分≤3定义为低风险,≥4定义为高风险(针对临床显著前列腺癌)。
  • 预测模型区分Gleason模式4+3与3+4的敏感度37%、特异度82%、准确率66%。
  • 回归分析中ADCT的p=0.03,ADCratio的p=0.0007。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the predictive roles of qualitative (PI-RADSv2) and quantitative assessment (ADC metrics), in differentiating Gleason pattern (GP) 3 + 4 from the more aggressive GP 4 + 3 prostate cancer (PCa) using radical prostatectomy (RP) specimen as the reference standard.

METHODS: We retrospectively identified treatment-naïve peripheral (PZ) and transitional zone (TZ) Gleason Score 7 PCa patients who underwent multiparametric 3T prostate MRI (DWI with b value of 0,1400 and where unavailable, 0,500) and subsequent RP from 2011 to 2015. For each lesion identified on MRI, a PI-RADSv2 score was assigned by a radiologist blinded to pathology data. A PI-RADSv2 score ≤ 3 was defined as "low risk," a PI-RADSv2 score ≥ 4 as "high risk" for clinically significant PCa. Mean tumor ADC (ADCT), ADC of adjacent normal tissue (ADCN), and ADCratio (ADCT/ADCN) were calculated. Stepwise regression analysis using tumor location, ADCT and ADCratio, b value, low vs. high PI-RADSv2 score was performed to differentiate GP 3 + 4 from 4 + 3.

RESULTS: 119 out of 645 cases initially identified met eligibility requirements. 76 lesions were GP 3 + 4, 43 were 4 + 3. ADCratio was significantly different between the two GP groups (p = 0.001). PI-RADSv2 score ("low" vs. "high") was not significantly different between the two GP groups (p = 0.17). Regression analysis selected ADCT (p = 0.03) and ADCratio (p = 0.0007) as best predictors to differentiate GP 4 + 3 from 3 + 4. Estimated sensitivity, specificity, and accuracy of the predictive model in differentiating GP 4 + 3 from 3 + 4 were 37, 82, and 66%, respectively.

CONCLUSIONS: ADC metrics could differentiate GP 3 + 4 from 4 + 3 PCa with high specificity and moderate accuracy while PI-RADSv2, did not differentiate between these patterns.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alessandrino F, Taghipour M, Hassanzadeh E, et al. Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer. Abdom Radiol (NY). 2019. PMID: 30066169. doi:10.1007/s00261-018-1718-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。